A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOG-AD)

PHASE3RecruitingINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

February 2, 2022

Primary Completion Date

May 6, 2027

Study Completion Date

July 1, 2027

Conditions
Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOG-AD)
Interventions
DRUG

Rozanolixizumab

"* Pharmaceutical form: Solution for infusion~* Route of administration: subcutaneous infusion~Participants will receive pre-specified doses of rozanolixizumab."

OTHER

Placebo

"* Pharmaceutical form: Solution for infusion~* Route of administration: subcutaneous infusion~Participants will receive placebo."

Trial Locations (80)

20057

RECRUITING

Mog001 50553, Washington D.C.

21287

RECRUITING

Mog001 50552, Baltimore

33612

RECRUITING

Mog001 50308, Tampa

44106

RECRUITING

Mog001 50571, Cleveland

55905

RECRUITING

Mog001 50104, Rochester

61637

RECRUITING

Mog001 50472, Peoria

66160

RECRUITING

Mog001 50074, Kansas City

78229

RECRUITING

Mog001 50568, San Antonio

80045

RECRUITING

Mog001 50101, Aurora

84108

RECRUITING

Mog001 50473, Salt Lake City

94304

RECRUITING

Mog001 50450, Palo Alto

85259-5452

RECRUITING

Mog001 50297, Scottsdale

32224-1865

WITHDRAWN

Mog001 50342, Jacksonville

02114-3117

RECRUITING

Mog001 50243, Boston

75390-9036

RECRUITING

Mog001 50304, Dallas

Unknown

RECRUITING

Mog001 30022, Melbourne

WITHDRAWN

Mog001 30026, Southport

RECRUITING

Mog001 40123, Anderlecht

RECRUITING

Mog001 40756, Bruxelles/brussel

RECRUITING

Mog001 40122, Edegem

RECRUITING

Mog001 40185, Ghent

RECRUITING

Mog001 60033, Porto Alegre

RECRUITING

Mog001 40195, Hradec Králové

RECRUITING

Mog001 40124, Prague

RECRUITING

Mog001 40721, Teplice

RECRUITING

Mog001 40657, Bron

WITHDRAWN

Mog001 40422, Caen

WITHDRAWN

Mog001 40130, Marseille

RECRUITING

Mog001 40755, Montpellier

RECRUITING

Mog001 40170, Strasbourg

RECRUITING

Mog001 40659, Berlin

RECRUITING

Mog001 40386, Cologne

RECRUITING

Mog001 40140, Göttingen

RECRUITING

Mog001 40177, Münster

RECRUITING

Mog001 40577, Ulm

RECRUITING

Mog001 40146, Pavia

RECRUITING

Mog001 40629, Roma

RECRUITING

Mog001 40646, Verona

RECRUITING

Mog001 20225, Bunkyō City

RECRUITING

Mog001 20068, Chiba

RECRUITING

Mog001 20307, Isehara

RECRUITING

Mog001 20049, Kitakyushu

RECRUITING

Mog001 20143, Kodaira

RECRUITING

Mog001 20223, Kōriyama

RECRUITING

Mog001 20224, Sendai

RECRUITING

Mog001 20227, Sendai

RECRUITING

Mog001 20070, Shinjuku-ku

RECRUITING

Mog001 20032, Suita

RECRUITING

Mog001 50486, Culiacán

RECRUITING

Mog001 50485, Mexico City

RECRUITING

Mog001 40840, Bydgoszcz

RECRUITING

Mog001 40485, Coimbra

RECRUITING

Mog001 40669, Porto

RECRUITING

Mog001 20226, Goyang-si

RECRUITING

Mog001 20104, Seoul

RECRUITING

Mog001 40267, Barcelona

RECRUITING

Mog001 40100, Madrid

RECRUITING

Mog001 40161, Madrid

RECRUITING

Mog001 40341, Málaga

RECRUITING

Mog001 40350, Murcia

RECRUITING

Mog001 40049, Seville

WITHDRAWN

Mog001 40660, Gothenburg

RECRUITING

Mog001 40663, Huddinge

RECRUITING

Mog001 40723, Basel

RECRUITING

Mog001 40337, Bern

RECRUITING

Mog001 40630, Zurich

RECRUITING

Mog001 20096, Changhua

RECRUITING

Mog001 20303, Kaohsuing CITY

RECRUITING

Mog001 20080, Taichung

RECRUITING

Mog001 20094, Tainan City

RECRUITING

Mog001 20304, Taipei

RECRUITING

Mog001 20082, Taiyuan

RECRUITING

Mog001 40550, Istanbul

RECRUITING

Mog001 40726, Izmir

RECRUITING

Mog001 40648, Samsun

RECRUITING

Mog001 40725, Sancaktepe

RECRUITING

Mog001 20319, Kyiv

RECRUITING

Mog001 20228, Ternopil

RECRUITING

Mog001 40661, Liverpool

RECRUITING

Mog001 40163, Oxford

All Listed Sponsors
lead

UCB Biopharma SRL

INDUSTRY